Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in The Netherlands

Journal of Hospital Infection

Volumn 79, Issue 3, 2011, Pages 198-201

  Bode, L G M ^a   Wertheim, H F L ^a   Kluytmans, J A J W ^b,c   Bogaers Hofman, D ^b   Vandenbroucke Grauls, C M J E ^c   Roosendaal, R ^c   Troelstra, A ^d   Box, A T A ^d   Voss, A ^e,f   van Belkum, A ^a   Verbrugh, H A ^a   Vos, M C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Meticillin; MRSA; Population based; Prevalence; Resistance; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; DRUG UTILIZATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NETHERLANDS; NONHUMAN; NOSE SMEAR; PRACTICE GUIDELINE; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NETHERLANDS; NOSE; PATIENT ADMISSION; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80053308803     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.05.009     Document Type: Article

References (32)

1. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
2. Wertheim H.F., Vos M.C., Boelens H.A., et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004, 56:321-325.
3. Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2010, European Center for Disease Prevention and Control, ECDC, Stockholm.
4. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17.
5. Martineau F., Picard F.J., Roy P.H., Ouellette M., Bergeron M.G. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol 1998, 36:618-623.
6. Tiemersma E.W., Bronzwaer S.L., Lyytikainen O., et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004, 10:1627-1634.
7. van de Sande-Bruinsma N., Grundmann H., Verloo D., et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008, 14:1722-1730.
8. Humphreys H. National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus - what do they tell us?. Clin Microbiol Infect 2007, 13:846-853.
9. Vandenbroucke-Grauls C.M. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996, 17:512-513.
10. Vos M.C., Behrendt M.D., Melles D.C., et al. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009, 30:977-984.
11. Bocher S., Skov R.L., Knudsen M.A., et al. The Search and Destroy strategy prevents spread and long-term carriage of MRSA; results from follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark. Clin Microbiol Infect 2010, 16:1427-1434.
12. van Trijp M.J., Melles D.C., Hendriks W.D., Parlevliet G.A., Gommans M., Ott A. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007, 28:970-975.
13. Armand-Lefevre L., Ruimy R., Andremont A. Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg Infect Dis 2005, 11:711-714.
14. Voss A., Loeffen F., Bakker J., Klaassen C., Wulf M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 2005, 11:1965-1966.
15. Huijsdens X.W., van Dijke B.J., Spalburg E., et al. Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob 2006, 5:26.
16. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
17. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005, 352:468-475.
18. Pan E.S., Diep B.A., Carleton H.A., et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003, 37:1384-1388.
19. Ferry T., Etienne J. Community acquired MRSA in Europe. BMJ 2007, 335:947-948.
20. Francois P., Harbarth S., Huyghe A., et al. Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis 2008, 14:304-307.
21. Hedin G., Fang H. Epidemiology of methicillin-resistant Staphylococcus aureus in Southern Stockholm, 2000-2003. Microb Drug Resist 2007, 13:241-250.
22. Cunha B.A. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Med Clin North Am 2006, 90:1165-1182.
23. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
24. van Belkum A., Melles D.C., Peeters J.K., et al. Methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398 in pigs and humans. Emerg Infect Dis 2008, 14:479-483.
25. van Loo I., Huijsdens X., Tiemersma E., et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 2007, 13:1834-1839.
26. Wulf M.W., Markestein A., van der Linden F.T., Voss A., Klaassen C., Verduin C.M. First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill 2008, 13:pii=8051.
27. Haenen A., Huijsdens X.W., Pluister G.N., et al. Surveillance of MRSA in the Netherlands in 2007: an increasing trend of livestock-related MRSA. Inf Bull 2009, 20:138-145.
28. Haenen A., Huijsdens X.W., Pluister G.N., et al. Surveillance of MRSA in the Netherlands in 2008. Inf Bull 2010, 21:162-169.
29. Haenen A. Registration of infectious diseases. Inf Bull 2011, 22:39.
30. Stam-Bolink E.M., Mithoe D., Baas W.H., Arends J.P., Moller A.V. Spread of a methicillin-resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands. Eur J Clin Microbiol Infect Dis 2007, 26:723-727.
31. Deurenberg R.H., Nulens E., Valvatne H., et al. Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region. Emerg Infect Dis 2009, 15:727-734.
32. Vos M.C., Ott A., Verbrugh H.A. Successful Search-and-Destroy policy for Methicillin-resistant Staphylococcus aureus in The Netherlands. J Clin Microbiol 2005, 43:2034-2035.